synergy nash tirzepatide in Tirzepatide for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH phase 2 trial Beyond glycemia: Comparing tirzepatide to

While Rybelsus will continue to be sold outside the U.S., the switch to the Ozempic brand domestically is permanent

The SELECT trial showed a 20% MACE reduction

Exercise Regularly: Moderate exercise can strengthen the heart and improve overall cardiovascular health, but patients should follow their doctors advice on what type of exercise is safe for them

(5) BPC 157 reduces the proteinprotein interaction between eNOS and Cav-1

Founded in 2012 by a team of scientists from Harvard, Stanford, UC Berkeley, and Johns Hopkins, and led by Co-founder and CEO Colleen Cutcliffe, Ph.D., Pendulum translates cutting-edge microbiome research into clinically studied, targeted microbial solutions